Brief: Anthera signs manufacturing agreement with Patheon

Anthera Pharmaceuticals

20/11/2014 16:00

Nov 20 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O : 
 * Anthera and patheon sign manufacturing agreement for liprotamase phase III registration trial 
 * Contract provides for patheon to support production of sollpura clinical drug product for co's phase III registration trial 
 * Says agreement allows for the production of various capsule and sachet formulations and dosage strengths 
 * Says clinical studies with sollpura are scheduled to begin in 2015 
 * Says has signed a manufacturing and supply agreement with the patheon division of dpx holdings b.v 
 
 * Source text for Eikon  ID:nPnc45Lk5  
 
 * Further company coverage  ANTH.O  
 ((Bangalore Newsroom; +1 646 223 8780))